[go: nahoru, domu]
h5-index představuje h-index článků publikovaných během pěti předchozích roků. Jedná se o největší počet (h) článků publikovaných v letech 2018–2022, které mají minimálně stejný počet citací (h).skrýt
h5-medián určitého publikačního zdroje je střední hodnota (medián) počtu citací článků, které se podílí na jeho h5-indexu.skrýt
Název/autorCitaceRok
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
JR Brahmer, C Lacchetti, BJ Schneider, MB Atkins, KJ Brassil, ...
Journal of Clinical Oncology 36 (17), 1714-1768
30372018
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
AC Wolff, MEH Hammond, KH Allison, BE Harvey, PB Mangu, ...
Journal of Clinical Oncology 36 (20), 2105-2122
19442018
Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
A Marabelle, DT Le, PA Ascierto, AM Di Giacomo, A De Jesus-Acosta, ...
Journal of Clinical Oncology 38 (1), 1-10
16772020
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
MJ Overman, S Lonardi, KYM Wong, HJ Lenz, F Gelsomino, M Aglietta, ...
Journal of Clinical Oncology 36 (8), 773-779
16162018
Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater
M Reck, D Rodríguez–Abreu, AG Robinson, R Hui, T Csőszi, A Fülöp, ...
Journal of Clinical Oncology 37 (7), 537-546
11692019
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
RS Finn, BY Ryoo, P Merle, M Kudo, M Bouattour, HY Lim, V Breder, ...
Journal of Clinical Oncology 38 (3), 193-202
11402020
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)
AM Young, A Marshall, J Thirlwall, O Chapman, A Lokare, C Hill, D Hale, ...
Journal of Clinical Oncology 36 (20), 2017-2023
11392018
Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update
K Oktay, BE Harvey, AH Partridge, GP Quinn, J Reinecke, HS Taylor, ...
Journal of Clinical Oncology 36 (19), 1994-2001
10922018
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
NS Key, AA Khorana, NM Kuderer, K Bohlke, AYY Lee, JI Arcelus, ...
Journal of Clinical Oncology 38 (5), 496-520
10792020
Molecular Determinants of Response to Anti–Programmed Cell Death (PD)-1 and Anti–Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non–Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing
H Rizvi, F Sanchez-Vega, K La, W Chatila, P Jonsson, D Halpenny, ...
Journal of Clinical Oncology 36 (7), 633-641
10772018
Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology
SG Mohile, W Dale, MR Somerfield, MA Schonberg, CM Boyd, ...
Journal of Clinical Oncology 36 (22), 2326-2347
10542018
Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial
P Ost, D Reynders, K Decaestecker, V Fonteyne, N Lumen, A De Bruycker, ...
Journal of Clinical Oncology 36 (5), 446-453
9702018
Five-Year Overall Survival for Patients With Advanced Non‒Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study
EB Garon, MD Hellmann, NA Rizvi, E Carcereny, NB Leighl, MJ Ahn, ...
Journal of Clinical Oncology 37 (28), 2518-2527
8462019
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
JD Merker, GR Oxnard, C Compton, M Diehn, P Hurley, AJ Lazar, ...
Journal of Clinical Oncology 36 (16), 1631-1641
8412018
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study
DR Gomez, C Tang, J Zhang, GR Blumenschein Jr, M Hernandez, JJ Lee, ...
Journal of Clinical Oncology 37 (18), 1558-1565
8362019
Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: MONALEESA-3
DJ Slamon, P Neven, S Chia, PA Fasching, M De Laurentiis, SA Im, ...
Journal of Clinical Oncology 36 (24), 2465-2472
8072018
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial
CE Kyriakopoulos, YH Chen, MA Carducci, G Liu, DF Jarrard, NM Hahn, ...
Journal of Clinical Oncology 36 (11), 1080-1087
7762018
CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia
JE Lancet, GL Uy, JE Cortes, LF Newell, TL Lin, EK Ritchie, RK Stuart, ...
Journal of Clinical Oncology 36 (26), 2684-2692
7602018
Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non–Small-Cell Lung Cancer
KC Arbour, L Mezquita, N Long, H Rizvi, E Auclin, A Ni, G Martínez-Bernal, ...
Journal of Clinical Oncology 36 (28), 2872-2878
7552018
Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non–Small-Cell Lung Cancer
S Gadgeel, D Rodríguez-Abreu, G Speranza, E Esteban, E Felip, ...
Journal of Clinical Oncology 38 (14), 1505-1517
7192020
1 - 20
Data a počty citací jsou odhady určené automaticky počítačovým programem.